Clinical and therapeutic implications of neuroendocrine prostate cancer: A long winding road to cure

Clinical and therapeutic implications of neuroendocrine prostate cancer: A long winding road to cure

Bibliographic Details
Main Authors:	Chia-Lung Tsai, Kevin Lu, Hua-Pin Wang, Victor Chia-Hsiang Lin, Tsan-Jung Yu
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2016-06-01
Series:	Urological Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S187952261630241X

Similar Items

Induction of Neuroendocrine Differentiation in Prostate Cancer Cells by Dovitinib (TKI-258) and its Therapeutic Implications
by: Shalini S. Yadav, et al.
Published: (2017-06-01)

Prostate tumor neuroendocrine differentiation via EMT: The road less traveled
by: Haley Dicken, et al.
Published: (2019-01-01)

Potential therapeutic effect of epigenetic therapy on treatment-induced neuroendocrine prostate cancer
by: Xiang Xu, et al.
Published: (2017-01-01)

Neuroendocrine aspects of prostate oncogenesis
by: P.V. Glybochko, et al.
Published: (2010-03-01)

Neuroendocrine differentiation in prostate cancer
by: Cerović Snežana J., et al.
Published: (2004-01-01)

Therapeutic targets in neuroendocrine tumours
by: Kostoula, V.
Published: (2010)

Neuroendocrine and Aggressive-Variant Prostate Cancer
by: Nicholas Spetsieris, et al.
Published: (2020-12-01)

Neuroendocrine carcinoma of the prostate (review of the literature)
by: Daria V Abbasova, et al.
Published: (2019-09-01)

Current advances of targeting epigenetic modifications in neuroendocrine prostate cancer
by: Wen-Chi Cheng, et al.
Published: (2021-01-01)

Clinical Epigenetics of Neuroendocrine Tumors: The Road Ahead
by: Annamaria Colao, et al.
Published: (2020-12-01)

Long non-coding RNAs in castration-resistant and neuroendocrine prostate cancer: Potential role and therapeutic impact
by: Kumari S. Prajapati, et al.
Published: (2020-12-01)

Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine prostate cancer
by: Chen, Ruiqi
Published: (2017)

Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma
by: Harrison K. Tsai, et al.
Published: (2017-11-01)

Estrogens and Their Receptors in Prostate Cancer: Therapeutic Implications
by: Erika Di Zazzo, et al.
Published: (2018-01-01)

VALUE OF THE DETECTION OF NEUROENDOCRINE DIFFERENTIATION IN PROSTATE CANCER
by: M. V. Kovylina, et al.
Published: (2014-07-01)

NEUROENDOCRINE CARCINOMA OF THE PROSTATE: A CASE REPORT
by: I. Ya. Skvortsov, et al.
Published: (2014-07-01)

Dermatomyositis associated with prostate adenocarcinoma with neuroendocrine differentiation
by: Hideyuki Minagawa, et al.
Published: (2021-01-01)

Immunohistochemical investigation of neuroendocrine component in prostate adenocarcinoma
by: Prokopyk O. V., et al.
Published: (2010-01-01)

Neuroendocrine differentiation in prostate cancer – a review
by: R. Popescu, et al.
Published: (2015-12-01)

NEUROENDOCRINE CARCINOMA OF THE PROSTATE: A CASE REPORT
by: I. Ya. Skvortsov, et al.
Published: (2014-07-01)

VALUE OF THE DETECTION OF NEUROENDOCRINE DIFFERENTIATION IN PROSTATE CANCER
by: M. V. Kovylina, et al.
Published: (2014-07-01)

Neuroendocrine Tumour of the Prostate: A Rare Variant
by: Ozer Ural Cakici, et al.
Published: (2013-12-01)

Distribution of Neuroendocrine Cells in the Transition Zone of the Prostate
by: Yuki Kyoda, et al.
Published: (2017-01-01)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
by: James Watson, et al.
Published: (2018-04-01)

ONECUT2 is a driver of neuroendocrine prostate cancer
by: Haiyang Guo, et al.
Published: (2019-01-01)

Hedgehog Signaling in Prostate Cancer and Its Therapeutic Implication
by: Karin Haustermans, et al.
Published: (2013-07-01)

Pancreatic Neuroendocrine Tumors: from diagnosis to therapeutics
by: Bárbara Costa Correia
Published: (2021)

WLS-Wnt signaling promotes neuroendocrine prostate cancer
by: Tyler Bland, et al.
Published: (2021-01-01)

The many faces of neuroendocrine differentiation in prostate cancer progression
by: Stephane eTerry, et al.
Published: (2014-03-01)

Targeting neuroendocrine prostate cancer: molecular and clinical perspectives
by: Panagiotis J Vlachostergios, et al.
Published: (2015-02-01)

Prostatic Metastasis of Pulmonary Large Cell Neuroendocrine Carcinoma
by: Kumi Shimizu, Taichiro Goto, Arafumi Maeshima, Yoshitaka Oyamada, Ryoichi Kato
Published: (2012-01-01)

Neuroendocrine differentiation in hormone resistant prostate cancer cells
by: Vias, Maria
Published: (2008)

Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer
by: Paloma Cejas, et al.
Published: (2021-10-01)

Cross Modulation between the Androgen Receptor Axis and Protocadherin-PC in Mediating Neuroendocrine Transdifferentiation and Therapeutic Resistance of Prostate Cancer
by: Stéphane Terry, et al.
Published: (2013-07-01)

A Case of Metastatic Gastric Neuroendocrine Tumor: Therapeutic Considerations
by: Shin Young Kim, et al.
Published: (2014-04-01)

Successes and Challenges on the Road to Cure Hepatitis C.
by: Stacy M Horner, et al.
Published: (2015-06-01)

Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation
by: Julia Lipianskaya, et al.
Published: (2014-08-01)

Identify Neuroendocrine Prostate Cancer (NEPC)-related lincRNA in Relapsed Prostate Cancer
by: Ting-Yu Cheng, et al.
Published: (2019)

Future Aspects of CDK5 in Prostate Cancer: From Pathogenesis to Therapeutic Implications
by: Muhammet Oner, et al.
Published: (2019-08-01)

N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway
by: Yu Yin, et al.
Published: (2019-01-01)